Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Atossa Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 67 | 77 | +10 |
| Shares | 19.2M | 26.2M | +6.98M (+36.3%) |
| Value | $34.6M | $31.2M | −$3.48M (−10.1%) |
New holders (27)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (17)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Laurion Capital Management LP | 2,225,800 | $4.01M |
| HRT Financial LP | 291,421 | $524.0K |
| Susquehanna International Group, LLP | 272,115 | $489.8K |
| Point72 Asia (Singapore) Pte. Ltd. | 140,858 | $253.5K |
| Y-Intercept (Hong Kong) Ltd | 114,341 | $205.8K |
| Simplex Trading, LLC | 55,589 | $100.0K |
| Balyasny Asset Management LLC | 42,981 | $77.4K |
| Jefferies Financial Group Inc. | 38,200 | $68.8K |
| CTC Alternative Strategies, Ltd. | 36,300 | $65.3K |
| Two Sigma Securities, LLC | 34,579 | $62.2K |
| ExodusPoint Capital Management, LP | 25,960 | $47.0K |
| Brevan Howard Capital Management LP | 13,666 | $24.6K |
| DRW Securities, LLC | 12,800 | $23.0K |
| Atria Wealth Solutions, Inc. | 10,000 | $18.0K |
| Old Point Trust & Financial Services N A | 250 | $450 |
| Macquarie Group Ltd | 1,735 | $3 |
| NBC Securities, Inc. | 150 | – |